All companies › ROIV

ROIV · Roivant Sciences Ltd.

Everything on this page is public record — SEC Form 4 filings and congressional disclosures — alongside any INSIDER SCANNER research case for this company.

Open-market buys0
Open-market sells5
Research cases0
Last filing2026-09-15

Insider flow: Selling only — a count of disclosed transactions, not a rating or a recommendation.

Insider transaction timeline

Every reported transaction, positioned by trade date. Purchases sit above the axis, sales below; circle area is proportional to dollar value. No share-price line is drawn — this feed carries transaction prices only, and a price history inferred from them would imply market data the filings do not contain.

Open-market purchase Open-market sale
2026-09-08 — Fitzgerald Meghan · sold 20,000 @ $39.90 2026-09-15 — Epperly Melissa B, · sold 4,338 @ $39.65 2026-09-15 — Epperly Melissa B, · sold 600 @ $40.38 2026-09-15 — Fitzgerald Meghan · sold 4,712 @ $39.68 2026-09-15 — Fitzgerald Meghan · sold 400 @ $40.45
2026-09-082026-09-15

Insider participation

One row per insider, one cell per reported transaction, shaded by value. Repeat buying and activity clustered in time are visible at a glance.

Fitzgerald Meghan Director
Epperly Melissa B, Director
Included with a free account

The analysis built on top of these filings

The filings above are public record and stay public here. What an account adds for $ROIV is the reading of them — and for this company, that is what the list below says it is, no more.

  • Transaction timelineThe [{'transaction_date': '2026-09-15', 'insider_name': 'Epperly Melissa B,', 'insider_title': 'Director', 'transaction_type': 'Open-market sell', 'shares': 4338.0, 'price': 39.65, 'value': 172001.7, 'is_buy': False}, {'transaction_date': '2026-09-15', 'insider_name': 'Epperly Melissa B,', 'insider_title': 'Director', 'transaction_type': 'Open-market sell', 'shares': 600.0, 'price': 40.38, 'value': 24228.0, 'is_buy': False}, {'transaction_date': '2026-09-15', 'insider_name': 'Fitzgerald Meghan', 'insider_title': 'Director', 'transaction_type': 'Open-market sell', 'shares': 4712.0, 'price': 39.68, 'value': 186972.16, 'is_buy': False}, {'transaction_date': '2026-09-15', 'insider_name': 'Fitzgerald Meghan', 'insider_title': 'Director', 'transaction_type': 'Open-market sell', 'shares': 400.0, 'price': 40.45, 'value': 16180.0, 'is_buy': False}, {'transaction_date': '2026-09-08', 'insider_name': 'Fitzgerald Meghan', 'insider_title': 'Director', 'transaction_type': 'Open-market sell', 'shares': 20000.0, 'price': 39.9, 'value': 798000.0, 'is_buy': False}] reported transactions plotted over the window rather than listed, so concentration is visible.

Not available for ROIV today: no reported open-market purchases in this window, so there is no insider cost basis to compute; no research case — nothing here has cleared the scoring threshold. Both appear on this page on their own if that changes.

A free account opens all of it.

Not financial advice. This page reports public filings and past research output. It is not a recommendation to buy or sell, and no price target here is a prediction. Trade at your own risk.